[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-research-council-of-norway-cell-and-gene-therapy-for-personalised-medicine-2027-01":3,"similar-research-council-of-norway-cell-and-gene-therapy-for-personalised-medicine-2027-01":33},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":9,"deadline_note":10,"duration":8,"trl":11,"relevance":8,"why_relevant":8,"early_career":12,"consortium":13,"first_seen":14,"last_updated":15,"update_note":8,"status":16,"stages":17,"call_frequency":18,"next_call_expected":8,"source_url":7,"created_at":19,"updated_at":20,"last_seen_at":20,"eligible_countries":21,"description":23,"seo_summary":24,"recurring_round":12,"canonical_id":4,"links":25},"research-council-of-norway-cell-and-gene-therapy-for-personalised-medicine-2027-01","Cell and Gene Therapy for Personalised Medicine","Research Council of Norway","https:\u002F\u002Fwww.forskningsradet.no\u002Fen\u002Fcall-for-proposals\u002FInternational-joint-calls\u002Fcell-and-gene-therapy-personalised-medicine\u002F",null,"2027-01-20T00:00:00.000Z","Pre-proposal deadline; call opens 4 November 2026; full proposal deadline 25 May 2027","3-6",false,"Required — interdisciplinary, cross-sectoral research consortium under EP PerMed","2026-10-18T00:00:00.000Z","2026-10-25T00:00:00.000Z","open","2-stage: pre-proposal (20 January 2027) → full proposal (25 May 2027)","Annual","2026-10-18T07:42:51.403Z","2026-10-25T08:03:50.730Z",[22],"NO","Encourages interdisciplinary and cross-sectoral research collaborations on developing and validating innovative cell and gene therapy for personalised medicine, under the European Partnership for Personalised Medicine (EP PerMed).","{\"summary\":\"This Research Council of Norway call, run through the EP PerMed partnership, funds interdisciplinary and cross-sectorial research consortia developing and validating cell and gene therapy approaches for personalised medicine, at technology readiness levels 3-6. It is a one-off call open to Norwegian participants in cross-national consortia, structured as a two-stage application process.\",\"meta_description\":\"Research Council of Norway funds cell and gene therapy consortia for personalised medicine, TRL 3-6, via EP PerMed, deadline 25 May 2027.\",\"who_should_apply\":[\"Researchers in Norway working on cell or gene therapy development\",\"Consortia spanning multiple disciplines and sectors (academia, clinical, industry)\",\"Projects at TRL 3-6, bridging early validation toward application\",\"Teams able to coordinate across the EP PerMed partnership structure\"],\"key_dates\":[\"Call opens 4 November 2026; pre-proposal deadline 20 January 2027\",\"Full proposal deadline 25 May 2027\",\"Two-stage process: pre-proposal then full proposal\"],\"tips\":[\"Form the cross-sectorial consortium early since EP PerMed calls require partners beyond a single academic discipline or sector.\",\"Position the project clearly within TRL 3-6, proposals too early-stage or too close to market may not fit the call's scope.\",\"Use the pre-proposal stage to establish the consortium's interdisciplinary rationale before investing in a full technical proposal.\"],\"faq\":[{\"q\":\"What is the deadline for the Cell and Gene Therapy for Personalised Medicine call?\",\"a\":\"The pre-proposal is due 20 January 2027, with the full proposal deadline on 25 May 2027.\"},{\"q\":\"Is this call recurring?\",\"a\":\"No, it is listed as a one-off call.\"},{\"q\":\"Do I need a consortium to apply?\",\"a\":\"Yes, an interdisciplinary and cross-sectorial research consortium is required under the EP PerMed partnership.\"},{\"q\":\"What technology readiness level does this call target?\",\"a\":\"Projects should fall within TRL 3-6, covering early proof-of-concept through validation stages.\"},{\"q\":\"Who is eligible to apply from Norway?\",\"a\":\"Norwegian researchers participating in the required cross-sectorial consortium, as this call is funded through the Research Council of Norway.\"}],\"tags\":[\"cell-therapy\",\"gene-therapy\",\"personalised-medicine\",\"research-council-of-norway\",\"ep-permed\",\"consortium-required\",\"translational-research\",\"norway\"]}",{"matchedProgram":8,"resourceSlug":8,"relatedGuides":26,"countryHubs":27,"domainHubs":28,"closingMonth":29,"hasRelated":12,"hasBrowseRelated":32},[],[],[],{"slug":30,"label":31},"2027-01","January 2027",true,{"grants":34},[35,40,46,51,55],{"id":36,"name":37,"funder":38,"deadline":39,"budget":8},"f-r-s-fnrs-fonds-de-la-recherche-scientifique-ep-permed-jtc-2027-cell-and-gene-therapy-for-perso","EP PerMed JTC 2027 – Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)","F.R.S.-FNRS (Fonds de la Recherche Scientifique)","2027-01-27T00:00:00.000Z",{"id":41,"name":42,"funder":43,"deadline":44,"budget":45},"cancer-research-institute-clinical-innovator-2026-12","Clinical Innovator","Cancer Research Institute","2026-12-01T00:00:00.000Z","$1M",{"id":47,"name":48,"funder":49,"deadline":50,"budget":8},"cancerfonden-next-steps-2026-12","Next steps","Cancerfonden","2026-12-15T00:00:00.000Z",{"id":52,"name":53,"funder":54,"deadline":8,"budget":8},"nordic-cancer-union-research-grant-2026","Research Grant","Nordic Cancer Union",{"id":56,"name":57,"funder":58,"deadline":8,"budget":59},"cancer-research-uk-childhood-cancer-therapeutic-catalyst-2026","Childhood Cancer Therapeutic Catalyst","Cancer Research UK","Up to £250k"]